The Patent Finder

Terms ending in 2037

Keygene N.V.

Every in-force patent on Keygene N.V.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,576,318Method for the Production of Haploid and Subsequent Doubled Haploid Plants
In force
 · High confidence
Keygene N.V.In forceHigh confidence
US 10,849,289Method for the Production of Haploid and Subsequent Doubled Haploid Plants
In force
 · High confidence
Keygene N.V.In forceHigh confidence
US 11,371,051Method for Targeted DNA Alteration in Plant Cells
In force
 · High confidence
Keygene N.V.In forceHigh confidence
US 11,060,100Nematode Resistance
In force
 · High confidence
Keygene N.V.In forceHigh confidence
US 12,331,309Method for Targeted Alteration of Duplex DNA
In force
 · High confidence
Keygene N.V.In forceHigh confidence
US 12,234,467Diplospory Gene
In force
 · High confidence
Keygene N.V.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited